Sign Up
 

The world is waiting for your results

Three steps to reach them faster.

Success is a Process.

Not an accident.

We help research teams improve their productivity by leveraging the power of rule-based automation to improve the quality and quantity of data produced by their labs. Using our laboratory automation platform, they can standardize and automate their laboratory workflows to produce more and better data that leads to faster and stronger results.

reproducibility
 

Reduce failure

Many accidental discoveries have shaped our world and many people have won the lottery

However, relying on chance to make the next discovery would be as foolish as playing the lottery to make a living.

Large sets of high-quality data are the foundation of scientific success. 

Small datasets cannot be generalized. Low-quality data are misleading.

Automation standardizes processes which reduces process failure and variability.
Reducing failure and uncontrolled variability reduces costs and improves quality. 

bigstock-woman-assistant-in-laboratory--118996781
 

Reduce costs

Automation reduces costs by allowing people to do a few things very well and very cheaply. It enables division of labor and economies of scale, two proven methods to achieve greater efficiency.  GenoFAB helps organizations adopt laboratory automation methods to extract actionable information from experimental data.

To remain competitive in the biotech marketplace, organizations must adopt new approaches that leverage the power of data analytics. The new bottleneck is no longer a lack of experimental capabilities; rather, it is the lack of processes that maximize the value of available resources.

drug-discovery-7
 

LIMS 101

Laboratory information management calls for the development of systems that best meet your lab's unique needs and distinctive workflows. 

I'm interested...

 

girl-laptop-lab
 

Step 1

Manage

 

Step 2

Automate

 

Step 3

Partner

 

Eliminate Waste

Increase reproducibility to reduce wasteful expenses

0%

of preclinical research budgets are wasted

0%

of scientists are facing reproducibility challenges

0

published articles based on misidentified cell lines.

testimonials-freedman

Leonard Freedman, Frederick National Laboratory

An analysis of past studies indicates that the cumulative (total) prevalence of irreproducible preclinical research exceeds 50%, resulting in approximately US$28,000,000,000 (US$28B)/year spent on preclinical research that is not reproducible—in the United States alone.  (PLOS Biology 16(4): e1002626)

testimonials-baker

Monya Baker, Nature

More than 70% of researchers have tried and failed to reproduce another scientist’s experiments, and more than half have failed to reproduce their own experiments. Those are some of the telling figures that emerged from Nature‘s survey of 1,576 researchers who took a brief online questionnaire on reproducibility in research. (Nature 533,452–454)

testimonials-hallfmann

Willem Halffman, Radboud University

While problems with cell line misidentification have been known for decades, an unknown number of published papers remains in circulation reporting on the wrong cells without warning or correction. Here we attempt to make a conservative estimate of this ‘contaminated’ literature. We found 32,755 articles reporting on research with misidentified cells, in turn cited by an estimated half a million other papers. (PLoS ONE 12(10): e0186281)

 

Needs

Companies come to GenoFAB because they need to...

... meet deadlines

They are facing aggressive deadlines to reach critical milestones. They have collected vast amounts of data but struggle to extract actionable information from them. Team members are uncertain how they can best contribute to project success.

... increase productivity

They are under intense pressure to increase productivity. They need to automate their processes but are unsure of their automation strategy. In some cases, they may have lost valuable data or samples.

... get results

They are facing reproducibility issues because their processes are poorly documented and they need to increase the quality of their data. They also need to collect more data and they need to scale up their research projects to reach strong conclusions.

7 min read

An Overview of Biosafety Levels

Biosafety levels refer to both physical and administrative barriers that combine to protect...

6 min read

HEK293: An Essential Human Cell Line with a Unexpected Origin

HEK 293 cells and their derived cell lines are widely used in research and biotechnology....

9 min read

Best Electronic Lab Notebooks of 2020

The COVID-19 pandemic induced slow down is a great opportunity to switch to an electronic...